...
首页> 外文期刊>Pediatrics: Official Publication of the American Academy of Pediatrics >PITUITARY ADRENOCORTICOTROPIC HORMONE (ACTH) AND 11-DEHYDRO-17 HYDROXY CORTICOSTERONE (CORTISONE) THERAPY IN THE LEUKEMIAS AND LYMPHOMAS OF CHILDREN
【24h】

PITUITARY ADRENOCORTICOTROPIC HORMONE (ACTH) AND 11-DEHYDRO-17 HYDROXY CORTICOSTERONE (CORTISONE) THERAPY IN THE LEUKEMIAS AND LYMPHOMAS OF CHILDREN

机译:白血病和儿童淋巴瘤的垂体肾上腺皮质激素(ACTH)和11-羟基17羟皮质酮(CORTISONE)治疗

获取原文
           

摘要

The data concerning 16 cases of leukemia and one case of lymphosarcoma in children treated with pituitary adrenocorticotropic hormone (ACTH) and 11-dehydro-17-hydroxy corticosterone (cortisone) are presented.Treatment of this group of diseases in children with these hormones resulted in complete but temporary remissions in a large proportion of the cases. Most patients in which remissions were produced were almost completely refractory to retreatment with the hormones. Chemical studies indicated that in those patients in which a remission was produced, coincident with the remission there was a mass destruction of leukemic tissue.Great variations were noted from patient to patient and also in the same patient in regard to the cytologic, physiologic and biochemical effects of the hormones.Although ACTH and cortisone are unsatisfactory for permanent treatment of the leukemias and lymphomas, they offer invaluable tools for the investigator in the study of these diseases.
机译:报道了垂体促肾上腺皮质激素(ACTH)和11-脱氢-17-羟基皮质酮(可的松)治疗的儿童的16例白血病和1例淋巴肉瘤的数据。在大多数情况下完成但暂时的缓解。大多数产生缓解的患者几乎完全无法接受激素治疗。化学研究表明,在产生缓解的患者中,与缓解同时发生的是白血病组织的大规模破坏。在细胞学,生理学和生化方面,患者之间以及患者之间存在巨大差异尽管ACTH和可的松不能长期有效地治疗白血病和淋巴瘤,但它们为研究这些疾病的研究者提供了宝贵的工具。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号